What’s Changing in Contract Manufacturing

Fortune Business Insights estimates that the global electronic manufacturing services (EMS) market will expand from USD 689.86B in 2026 to USD 1.16T by 2034. Additionally, Grand View Research sizes the pharmaceutical contract development & manufacturing (CDMO) market at USD 293.6B by 2033.

This shows how quickly high-volume contract manufacturing is scaling in electronics across consumer, automotive, industrial, aerospace/defense, and healthcare end-markets. It also indicates a demand curve for biologics, sterile fill-finish, and advanced therapeutics.

IQVIA’s Global Use of Medicines 2024 outlook links the outsourcing thesis to end-demand. Annual medicine use is forecast to reach 3.8 trillion defined daily doses by 2028. IQVIA separately states that global medicine spending is expected to reach approximately USD 2.3T by 2028.

This is a two demand-side signals that reinforce why pharma and medtech sponsors continue to lock in CDMO capacity through multi-year supply and fill-finish agreements.

PwC’s 2025 Digital Trends in Operations Survey (based on 610 operations and supply chain leaders) highlights how volatility is translating into execution choices for contract manufacturers. 57% report integrating AI into selected functions or across their organization, while 91% say they’ll significantly change supply chain strategies due to US trade policy changes.

2026 Market Outlook and Demand Drivers

UNIDO’s quarterly manufacturing/trade tracking shows global manufacturing production increased 0.7% in Q3 2025 (q/q) while manufacturing exports rose 1.7% (q/q). It notes that higher-technology goods production grew 1.4% (q/q).

According to Mordor Intelligence, the contract manufacturing market size is estimated to reach USD 966.84 billion by 2030, at a CAGR of 5.98%.

 

 

The contract manufacturing segment includes approximately 1406 startups within a base of 11 300 total companies. It indicates a market where entrepreneurial activity persists alongside established manufacturers. Despite this scale, the contract manufacturing segment records a yearly growth rate of -1.08%, which reflects consolidation and selective exits rather than broad-based expansion.

 

 

Notable Startup Use Cases in Contract Manufacturing

Master Care specializes in Contract Manufacturing for Cosmetics

Turkish startup Master Care designs original equipment manufacturing (OEM) and original design manufacturing (ODM) cosmetic contract manufacturing.

It builds products through a structured workflow that begins with concept and formulation design. The startup uses in-house research and development for stability, microbiological, and compatibility testing. It also applies manufacturing processes aligned with ISO 22716 good manufacturing practice (GMP) standards.

Moreover, the startup creates brand-specific formulations under its ODM model and produces existing client formulas under OEM agreements with strict confidentiality controls.

It provides high-capacity bulk manufacturing for brands that manage their own filling and packaging and delivers integrated filling, labeling, packaging, and export documentation services for delivery.

EveryChef offers Contract Food Manufacturing for Ready-to-Eat Meals

Australian startup EveryChef builds contract manufacturing and private label food production solutions for food service operators and consumer brands. It designs food products through a controlled workflow that employs recipe development, shelf-life testing and validation, nutritional and allergen compliance, and HACCP-approved manufacturing processes.

The startup creates frozen food service kits and ready-to-eat meal formats through standardized batch production. Its custom packaging designs and transparent pricing structures support consistent production scaling. Moreover, it deploys manufacturing programs that address multiple dietary specifications. These programs cover vegan, vegetarian, gluten-free, dairy-free, and allergen-managed requirements.

Trison Wells designs Contract Manufacturing Solutions for Household and Personal Care

Trison Wells is a US-based startup that develops contract manufacturing solutions for cleaning and personal care products. It operates a manufacturing workflow that integrates custom formulation with controlled batch production.

The startup manages filling processes to produce detergents, multipurpose cleaners, disinfectants, and personal care items such as hand soaps and hair and body washes.

Moreover, it designs formulations to align with client specifications and manages product categories spanning household cleaning, laundry care, pet care, automotive cleaning, and personal hygiene.

Infocus Remedies provides Contract Manufacturing for Pharmaceutical

Indian startup Infocus Remedies manufactures solid oral pharmaceutical formulations across acute and chronic therapy areas.

Its vertically integrated production model combines in-house formulation and development, analytical laboratories, and automated manufacturing to produce tablets, capsules, and effervescent dosages.

Moreover, it develops products across the central nervous system, cardiovascular, metabolic, anti-infective, and pain management segments. The startup uses high-capacity infrastructure to ensure consistent quality and batch reliability.

Yumari enables AI Infrastructure for Cross-Border Manufacturing

Mexican startup Yumari creates AI infrastructure products for cross-border contract manufacturing, including the pertinence matchmaking engine and the regional intelligence cloud.

These solutions match brands with suitable factories and forecast production performance. They use machine learning (ML) models trained on regional manufacturing data to detect quality risks and coordinate logistics.

It’s autonomous quality assurance, smart production forecasting, and AI-driven material analysis standardize supplier selection and manufacturing execution across apparel and textile supply chains.

Moreover, the integration of product development tools, such as AI-enhanced design, tech pack generation, and rapid prototyping, translates concepts into production-ready specifications.

Key Innovation Themes

The contract manufacturing segment holds 65 patents filed by 52 applicants. It signals targeted rather than widespread intellectual property development. A yearly patent growth rate of -1.39% confirms a slowdown in new patent filings, as companies prioritize operational execution and scale over technology creation.

Discover the emerging trends in the contract manufacturing market along with their firmographic details:

 

 

Sustainable Manufacturing shifts contract manufacturers from cost-only optimization to lifecycle accountability. Across 5500 companies and 831 900 employees, manufacturers embed carbon accounting, energy benchmarking, and material traceability into production contracts. The addition of 110 employees in the last year reflects hiring in compliance engineering, environmental reporting, and supplier auditing. With an annual growth rate of 2.38%, sustainability shapes supplier selection, pricing structures, and long-term outsourcing agreements, particularly in regulated industries such as electronics, automotive, and medical devices.

On-demand Manufacturing restructures how contract manufacturers allocate capacity and price production. Among 1100 companies employing 70 900 workers, this segment prioritizes digitally triggered production runs, reconfigurable tooling, and software-driven scheduling over fixed-volume contracts. The increase of 32 employees signals demand for production planners, automation engineers, and order orchestration roles rather than traditional operators. With a growth rate of 4.75%, on-demand manufacturing enables contract manufacturers to monetize idle capacity, improve product iteration, and serve customers shifting from forecast-based procurement to demand-driven sourcing.

Digital Manufacturing strengthens operational visibility and execution across distributed production networks. The segment includes 1900 companies employing 150 400 professionals, with 47 new employees added in the last year. At an annual growth rate of 3.98%, digital manufacturing adoption accelerates as manufacturers deploy data-driven systems to improve planning accuracy, quality control, and production coordination. This segment positions digital infrastructure as an enabler of scalable, multi-site contract manufacturing operations.

Where the Money Is Moving in Contract Manufacturing

Novo Holdings’ acquisition of Catalent was completed as an all-cash transaction valued at approximately USD 16.5 billion. This is a signal that sponsor-backed capacity platforms (especially in sterile fill-finish and biologics-related operations) are being treated as strategic infrastructure rather than interchangeable suppliers.

In the same transaction ecosystem, Novo Nordisk’s announcement specifies it will acquire three sterile fill-finish manufacturing sites for an upfront payment of USD 11 billion, and that the three sites employ more than 3000 people.

This is an example of how demand for specific dosage-form capacity is translating into asset transfers rather than only “capacity reservation” contracts.

The database records an average investment value of USD 35.9 million per funding round. It indicates mid- to late-stage capital deployment focused on capacity expansion, automation, and compliance-driven upgrades.

More than 1900 investors actively participate in the segment, which shows broad institutional and strategic interest rather than dependence on a small capital base.

The contract manufacturing segment closed over 2000 funding rounds. It shows sustained deal activity and continuous capital inflow across multiple sub-segments.

These investments collectively support more than 979 companies and indicate a diversified allocation of capital across contract manufacturers instead of heavy concentration in a few dominant players.

The combined investment value by leading contract manufacturing investors exceeds USD 9.22 billion. Here is a breakdown of their contributions:

 

 

Sanofi expanded its manufacturing partnership by selling its Ridgefield, New Jersey, sterile manufacturing site to Thermo Fisher, which continues producing Sanofi’s medicines at the facility. Cosette agreed to acquire Mayne Pharma for approximately USD 430 million, which would expand its platform in women’s health and dermatology.

Ardian lists Ourvita and HBI in its portfolio as contract development and manufacturing organizations (CDMOs) serving nutritional supplements, medical devices, cosmeceuticals, probiotics, and food and beauty segments. Altaris acquired Meridian Medical Technologies from Pfizer to strengthen its portfolio in complex drug-device manufacturing for commercial and government programs.

Sources Used in This Report

This contract manufacturing industry outlook draws on the StartUs Insights Discovery Platform to map the outsourcing economy across 9M+ companies, 25K+ technologies & trends, and 190M+ patents, news articles, and market reports. The analysis treats contract manufacturing as an execution layer – where capacity, compliance, and cycle-time discipline translate directly into competitive advantage.

It focuses on the operating systems that determine whether outsourced production actually scales – supplier qualification and transfer packs, quality management (GxP/ISO/IATF), MES/traceability, automation and inspection, capacity planning, and resilience across multi-site networks. It also tracks how contract manufacturing demand is being operationalized through footprint expansion and capex, consolidation and asset transfers, and more.